PERFORMANCE SHARE AWARD AGREEMENTPerformance Share Award Agreement • February 19th, 2020 • Cryolife Inc • Surgical & medical instruments & apparatus • Georgia
This Performance Share Award Agreement (together with the Performance Share Award Grant Notice to which this Agreement is attached, the “Agreement”) is made as of the Date of Grant set forth in the Grant Notice by and between CryoLife, Inc., a Florida corporation (the “Company”), and _________ (the “Participant”). Capitalized terms used but not specifically defined herein shall have the meanings specified in the Plan, the Grant Notice, or this Performance Share Award Agreement.
CRYOLIFE, INC. EQUITY AND CASH INCENTIVE PLAN PERFORMANCE SHARE AWARD AGREEMENTPerformance Share Award Agreement • February 19th, 2020 • Cryolife Inc • Surgical & medical instruments & apparatus
Unless otherwise defined herein, the terms defined in the CryoLife, Inc. Equity and Cash Incentive Plan (the “Plan’) will have the same defined meanings in this Performance Share Award Agreement, including the Notice of Stock Unit Grant (the “Notice of Grant”) and the Terms and Conditions of Performance Share Award, attached hereto as Exhibit A, together the (“Award Agreement”).
CLINICAL RESEARCH AGREEMENTClinical Research Agreement • February 19th, 2020 • Cryolife Inc • Surgical & medical instruments & apparatus
This Clinical Research Agreement (“Agreement”) is entered into this 10th day of October, 2019, (“Effective Date”) by and between CryoLife, Inc. (“Sponsor”), a corporation with its principal place of business at 1655 Roberts Boulevard, NW, Kennesaw, Georgia 30144, and Duke University, a tax-exempt research and educational institution acting for and on behalf of its Duke Clinical Research Institute (“Duke”), with an office at 300 West Morgan Street, Suite 800, Durham, North Carolina 27701 (individually, a “Party” and collectively, the “Parties”).
